Abstract:Objective Thyrotropin receptor antibodies(TRAb)include thyroid stimulating antibody (TSAb) and thyroid stimulating blocking antibody(TSBAb).It is very helpful to detect seFum TSAb and TSBAb levels in patients with thyroid diseases.The aim of this study was to establish two enzyme linked immunosorbent assay(EUSA)methods(N method and C method)that may determine serum TSAb and TSBAb levels respectively.The initial clinical application in thyroid diseases was also investigated.Methods Recombinant human thyroid stimulating hormone receptor(TSHR)-ecd N-terminal fragment was used in N method and C-terminal fragment was used in C method as antigens respectively.Two ELISA methods for detection of TSAb and TSBAb were established and evaluated.The absorbance value A405 was used as the quantitative parameter to reflect the level of TRAb.The serum TSAb and TSBAb levels were measured in 229 healthy controls,and 675 patients.They were 451 untreated Graves disease(GD),104 untreated chronic lymphocytic thyroiditis(Hashimoto disease,HT)complicating hypothyroidism,35 simple goiters,47 nodular goiters and 38 subacute thyroiditis.The ANOVA and X2-test were used for statistic data analysis.Results N method:(1)the serum TRAb levels measured with N method were positively correlated with commercial TSAb kit(r=0.7422.P＜0.05).(2)The intra-assay coefficient of variation(CV)and the inter-assay CV were 3.96%-4.67% and 7.32%-8.33%,respectively.(3)A405 (x-±s)value in healthy group was 0.44±0.15 with a cut-off value(x-+2s)of 0.74.(4)In untreated GD group,A405 was 0.93±0.28,which was significantly higher than that in healthy group(F=2.0341,P=0.001).The positive rate was 82.8%.(5)In untreated HT complicating hypothyroidism group,A405 was 0.64±O.23,which was significantly higher than that in healthy group(F=1.7822,P=0.003).The positive rate was 62.1%.C method:(1)intrs-assay CV and inter-assay CV were 3.24%-4.72% and 7.22%-8.55%,respectively.(2)The measured A405 value in healthy group was 0.56±0.11 with a cut-off valRe(x-+2s) of 0.78.(3)In untreated HT complicating hypothyroidism group,A405(x-±s) was 1.17±0.26,which was significantly higher than that in healthy group(F=3.0333,P=0.002).The positive rate was 93.4%.(4)In untreated GD group,A405 was 0.74±0.23,which was significantly higher than that in healthy group(F=1.8339,P=0.03).The positive rate was 66.3%.There were no significant difierences among simple goiter,nodular goiter,subacute thyroiditis and healthy groups(N method:F=1.6134,1.5772,1.6208,C method:F=1.5910,1.5369,1.6055,all P＞0.05)assayed with both N method and C methods.Conclusions The present novel N method may mainly measure TSAb level and C method mainly measure TSBAb levels.The two ELISA methods showed to be accurate,stable and convenient.It may be helpful for clinical evaluation in GD,HT and other thyroid diseases.

[A Novel Microbeads-Based Chemiluminescence Immunoassay for Detecting Human Thyrotropin].

Development of a Sensitive, Rapid, Biotin-Streptavidin Based Chemiluminescent Enzyme Immunoassay for Human Thyroid Stimulating Hormone.

A Highly Sensitive Chemiluminescence Immunoassay Technique for Assaying TSH in Human Serum

Development Of A Highly Sensitive And Selective Microplate Chemiluminescence Enzyme Immunoassay For The Determination Of Free Thyroxine In Human Serum

Magnetic Particle-Based Chemiluminescence Enzyme Immunoassay for Free Thyroxine in Human Serum

A New Thyroxine-Labeled Alkaline Phosphatase Chemiluminescence Immunoassay for Detection of Thyroxine Hormone

Application of europium(III) chelates-bonded silica nanoparticle in time-resolved immunofluorometric detection assay for human thyroid stimulating hormone.

Clinical application of chemiluminescence enzyme immunoassay to quantitatively detect human thyroid peroxidase antibodies

A rapid and sensitive chemiluminescent immunoassay of total thyroxin with DMAE·NHS-labeled

A homogeneous electrochemiluminescence immunoassay platform based on carbon quantum dots and magnetic beads enrichment for detection of thyroglobulin in serum

Analytical and Clinical Evaluation of the Light-Initiated Chemiluminescent Assays for Measurement of Human Thyroid Hormones

Label-free and Rapid Electrical Detection of Htsh with CMOS-compatible Silicon Nanowire Transistor Arrays.

Evaluation of a Newly Developed Chemiluminescence Immunoassay for Detecting Cardiac Troponin T

Reagentless electrochemiluminescent detection of protein biomarker using graphene-based magnetic nanoprobes and poly-L-lysine as co-reactant.

Nanogold-functionalized magnetic beads with redox activity for sensitive electrochemical immunoassay of thyroid-stimulating hormone.

A Time-Resolved Fluorescence Lateral Flow Immunochromatographic Assay Based on Oriented Immobilized Antibodies for the Ultrasensitive Detection of C-peptides in Human Serum.

A novel human TSHR antibody ELISA using recombinant extracellular domain fragments of human TSH receptor as antigen and initial clinical evaluation

Sensitive Time-Resolved Fluoroimmunoassay for Simultaneous Detection of Serum Thyroid-Stimulating Hormone and Total Thyroxin with Eu and Sm As Labels

Chemiluminescent Enzyme Immunoassay for Cardiac Troponin I Detection - Optimization of Experimental Parameters

Enhanced Photon Emission of Chemiluminescent Luminophore for Ultra-Fast and Semi-Automatic Immunoassay toward Single Molecule Detection.

An Electrochemiluminescence Immunosensor for Thyroid Stimulating Hormone Based on Polyamidoamine-Norfloxacin Functionalized Pd-Au Core-Shell Hexoctahedrons As Signal Enhancers